Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene

EU orphan designation number: EU/3/12/957   
Active ingredient: Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene
Indication: Treatment of X-linked chronic granulomatous disease
Sponsor: Généthon
1 bis rue de l’internationale, 91000 Evry, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2012 Orphan designation EMA/OD/118/11 (2012)883 of 09/02/2012